Efficacy, Safety and Cost Effectiveness of Four Therapeutic Agents for Treatment of Scabies

Not Applicable

• Conditions: Skin and Connective Tissue Diseases; scabies

• Registration Number: PACTR201505001116484

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-04-25
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 250

Inclusion Criteria

scabies; patients experiencing itching that involved at least three distinct sites on the body and had lesions that were characteristic of scabies
history of nocturnal itching
history of involvment of family members
history of contact with scabies pateint
presence of classical burrows on clinical examination
presence of typical scabietic lesions like,papules, nodules and vesicles
either gender
above 5years of age
willing to participate

Exclusion Criteria

Pregnant or lactating women.
Children < 5 years old and adult >50 years old.
body weight less than 15 kg.
Participants had a general condition such as abnormal liver and kidney functions, known thyroid disease, cardiac disorders, nervous system disorder, and psychiatric illnesses.
participants with history of diabetes mellitus, hypertension, or chronic infectious diseases.
Participants with any other associated skin disease, which could alter the picture of scabies.
immunocompromised individuals, having scabies with atypical presentations like crusted scabies.
Participants who had taken any antiscabetic treatment in the preceding month.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
complete absence of new lesions at the time of follow up and by negative parasitological examination of the patient

Secondary Outcome Measures

Name	Time	Method
adverse drug reaction